Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
PEG化およびジグリコシル化されたエリスロポエチン
Document Type and Number:
Japanese Patent JP2005509609
Kind Code:
A
Abstract:
This invention is directed to an erythropoietin mutein having in vivo biological activity for causing bone marrow cells to increase production of reticulocytes and red blood cells, in that the mutein is N-glycosylated at Asn38 and Asn83 but not N-glycosylated at Asn24. Such muteins have improved pharmaceutical properties.

More Like This:
JP2020037538PHARMACEUTICAL USE OF PROKARYOTIC MICROORGANISM-DERIVED POLYPEPTIDE HAVING ANGIOTENSIN-CONVERTING ENZYME 2 ACTIVITY
JP2015532594Stabilized protein for immunization against STAPHYLOCOCCUSAUREUS
JP2016049074YEAST WITH HIGH CONTENTS OF γ-GLU-ABU AND/OR γ-GLU-ABU-GLY
Inventors:
Tisher, Wilhelm
Application Number:
JP2003532536A
Publication Date:
April 14, 2005
Filing Date:
September 20, 2002
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
F. HOFFMANN-LA ROCHE AKTIENGESELLSCHAFT
International Classes:
C12P21/02; A61K38/22; A61K47/48; A61P7/06; C07K14/505; C12N15/12; A61K38/00; (IPC1-7): C07K14/505; A61K38/22; A61P7/06; C12P21/02
Attorney, Agent or Firm:
Hajime Tsukuni
Fumio Shinoda



 
Previous Patent: ベンゼンスルホニル化合物の製造方法

Next Patent: 皮膚の表皮障壁発達の増進